TRVI Competitors & Alternatives
Compare Trevi Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRVI
Main Stock$12.94
Tradestie Score
69
Market Cap
$1.14B
Analyst Upside
+117.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$6.61
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$65.57
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$39.69
|
$1.90B | 26.3 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.05
|
$1.84B | - | 65 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.12
|
$1.81B | - | 42 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.37
|
$1.78B | - | 66 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.77
|
$1.78B | - | 57 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$135.47
|
$1.77B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$22.82
|
$1.74B | - | 45 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.97
|
$1.68B | - | 64 | Compare |
More TRVI Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry